There is a significant autoimmune disease prevalence in psoriasis patients

Researchers at Yale School of Medicine have identified a significant association between psoriasis and obsessive-compulsive disorder...

Older age is linked to shorter intervals between the diagnosis of PsO and PsA.

Tildrakizumab was shown to be efficacious in treating moderate-to-severe plaque psoriasis on the scalp.

Topical treatment decreases itch and improves sleep patterns in patients with psoriasis and atopic dermatitis.

The visibility of a skin disorder is directly linked to stigma including bullying.

Topical melatonin and topical rosuvastatin were both effective in reducing the severity of mild-to-moderate plaque PsO.

Guselkumab is efficacious in patients with moderate-to-severe psoriasis and a history of cancer.